Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET-PA) Invested Capital (2016 - 2025)

Historic Invested Capital for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $44.5 billion.

  • Metlife's Invested Capital fell 420.09% to $44.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $44.5 billion, marking a year-over-year decrease of 420.09%. This contributed to the annual value of $42.8 billion for FY2024, which is 681.84% down from last year.
  • Latest data reveals that Metlife reported Invested Capital of $44.5 billion as of Q3 2025, which was down 420.09% from $43.3 billion recorded in Q2 2025.
  • Metlife's Invested Capital's 5-year high stood at $83.9 billion during Q2 2021, with a 5-year trough of $39.8 billion in Q3 2022.
  • Its 5-year average for Invested Capital is $52.7 billion, with a median of $45.0 billion in 2023.
  • In the last 5 years, Metlife's Invested Capital plummeted by 5218.55% in 2022 and then surged by 1226.01% in 2024.
  • Over the past 5 years, Metlife's Invested Capital (Quarter) stood at $64.3 billion in 2021, then plummeted by 30.08% to $44.9 billion in 2022, then grew by 2.16% to $45.9 billion in 2023, then fell by 6.82% to $42.8 billion in 2024, then grew by 3.98% to $44.5 billion in 2025.
  • Its last three reported values are $44.5 billion in Q3 2025, $43.3 billion for Q2 2025, and $42.4 billion during Q1 2025.